Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

$1.1T spending bill suspends device and insurance taxes

The House of Representatives released specifics on a $1.1 trillion funding bill that includes a package of tax breaks, coming down to the wire on Tuesday, Dec. 15, to finalize the bill by the deadline.

CHIME to CMS: Hold off on Stage 3

The College of Healthcare Information Management Executives (CHIME) is urging the federal government to give healthcare providers more time to adjust to recent changes to the Meaningful Use program before mandating new and burdensome Stage 3 requirements.

Thumbnail

AEI panel examines medical malpractice

The American Enterprise Institute (AEI) held a panel discussion earlier this month, discussing medical malpractice reform along with a variety of other topics. 

Thumbnail

Year in Review: ICD-10 finally happens

Maybe you’re familiar with a little effort called ICD-10 that has been the subject of delays, debate, regulations, contingencies and more for several years now.

Senate votes to appeal Obamacare Cadillac tax

The Senate voted 90-10 to repeal Obamacare’s “Cadillac tax” on high-cost health plans, a rare instance of bipartisanship around the contentious healthcare law. 

Why did 11% of organizations call ICD-10 transition a 'failure'?

Another survey indicates that the Oct. 1 transition to ICD-10 went smoothly for most healthcare providers, but 11 percent said it was a failure, according to KPMG. 

Thumbnail

For-profit players have a place in universal healthcare systems: Canadian study

In a study of healthcare systems in six developed nations that could have implications for the U.S.—regardless of the ultimate fate of troubled Obamacare—an influential Canadian think tank has concluded that for-profit hospitals and insurers can survive and thrive under universal health care.

CMS clarifies actions regarding ICD-10 claims problems

Overall, there have been few complaints in the wake of the transition to ICD-10 but a few isolated incidents have led the Centers for Medicare & Medicaid Services (CMS) to issue clarifications on how it's resolving the issues.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup